Desmoid tumor differential diagnosis

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Overview

Desmoid tumor must be differentiated from acute hematoma, lymphoma, fibrosarcoma, rhabdomyosarcoma, liposarcoma, leiomyosarcoma, neurofibroma, benign fibrous tumor and primitive neuroectodermal tumor.

Differentiating Desmoid tumor from other Diseases

Disease entity Etiology (Genetic or others) Histopathological findings Immunohistochemical staining Benign/Malignant Risk factors Common site of involvement Clinical manifestations Other associated findings
Desmoid tumor Sporadic desmoids are associated with following mutations:
  • Wnt/beta-catenin signaling pathway
  • Mutations in CTNNB1 (Beta-catenin gene) (85%)
  • APC gene mutations (10-15%)

Familial desmoids/Hereditary desmoid disease is associated with:

  • Mutation in second copy of APC gene

Pediatric desmoids have following additional mutations involving:

  • AKT1 E17K (31%)
  • BRAF V600E (19%)
  • TP53 R273H (9%)
Histologically, desmoid tumors consist of:
  • Linearly arranged elongated fibroblasts and myofibroblasts
  • Characterized by elongated, tapered cytoplasm; elongated, vesicular, typical-appearing nuclei; and multiple small nucleoli
  • Surrounded and separated from each other by collagen
Positive for:
  • Nuclear beta-catenin (90%)
  • Vimentin
  • Alpha smooth muscle actin
  • Muscle actin

Negative for:

  • Desmin
  • Cytokeratins
  • S-100

Positive antibodies for:

  • Smooth muscle actin
  • Desmin
  • KIT
  • Benign
  • High local aggressive infiltration
  • High local recurrence
  • Familial adenomatous polyposis (FAP)
  • Gardner syndrome (inherited desmoids)
  • Turcot syndrome
  • Specific location of APC (adenomatous polyposis coli) gene mutation i.e. 3' end of the APC gene, specifically between codons 1445 and 1580
  • Family history of desmoid tumor
  • Family history of colon cancer/FAP
  • Estrogen therapy
  • Oral contraceptive pills
  • Pregnancy
  • History of antecedent surgical/accidental trauma at the tumor site (30%)
  • History of breast cancer
  • History of repeated irradiation to a certain body part
  • Female gender
  • Sex hormones/androgens
  • Abdominal wall (intra-abdominal desmoids)
  • Extra-abdominal desmoids may involve:
    • Shoulder girdle
    • Upper arms
    • Upper legs
    • Hip/buttock region
    • Trunk
    • Head
    • Neck
    • Breast (history of breast cancer/breast surgery
  • Intra-abdominal desmoids may involve:
    • Mesentery
    • Retroperitoneum
    • Bowel
  • Asymptomatic
  • Painless/painful lump in affected area
  • Pain or soreness caused by compressed nerves or muscles
  • Limping or other difficulty using the legs, feet, arms or hands
  • Decreased movement or range of motion
  • Nausea
  • Vomiting
  • Breast mass (in case of breast desmoids)
  • Loss of sleep
  • Anxiety
  • Abdominal mass/pain
  • Constipation
  • Bloating
  • Intestinal rupture
  • Rectal bleeding
  • Compression of kidneys, ureters, mesenteric vessels and vena cava
Desmoids may be associated with following:
  • Other sporadic tumors such as:
    • Dupuytren's contracture
    • Plantar fibrosis
    • Peyronie's disease
    • Carpal tunnel syndrome
    • Infantile fibrosarcoma
    • Fibrous dysplasia
  • Trisomy 8
  • Trisomy 20
Fibrosarcoma/Fibroblastic sarcoma
  • Unknown precise cause
  • Genetics may play a role
  • Tumor cells resemble mature fibroblasts (spindle-shaped), secreting collagen, with rare mitoses
  • Spliting and merging cells arranged in short fascicles giving "fish bone" appearnace
  • Immature blood vessels (lacking endothelial cells) favor the bloodstream metastasizing
  • "Herringbone" pattern of cell arrangement
Strongly positive for:
  • Vimentin

Negative for:

  • Desmin
  • Smooth muscle actin
  • HHF-35
  • Osteocalcin
  • CD-68
  • LCA
  • s100
  • HMB-45
  • CD-31
  • CD-34
  • Cytokeratin
  • Epithelial membrane antigen
  • CD-99
  • Malignant (with metastatic potential)
  • Familial adenomatous polyposis
  • Li-Fraumeni syndrome
  • Neurofibromatosis type 1
  • Nevoid basal cell carcinoma syndrome
  • Retinoblastoma
  • Tuberous sclerosis
  • Werner syndrome
  • Giant cell tumor
  • Enchondroma
  • Fibrous dysplasia
  • Bizarre parosteal osteochondromatous proliferation
  • Chronic osteomyelitis
  • Paget's disease
  • Radiation therapy
  • Surgically treated fracture
  • Bone infarction
  • Exposure to certain chemicals, such as thorium dioxide, vinyl chloride, or arsenic
  • Lymphedema, a swelling in the arms and legs
Primary bone malignancy involving end of long bones:
  • Upper end of tibia
  • Lower end of femur
  • Localized Pain
  • Swelling
  • Loss of range of motion
  • Pain with weight-bearing
  • Night pain
  • Pathologic fracture of affected bone
  • Moth-eaten appearance on Xray
Low-grade fibromyxoid sarcoma[4][5][9][10][11][12][13][14] Translocation:
  • t(7;18;16) or
  • t(7;16) (q34:p11)

Fusion gene:

  • FUS/CREB3 L2 (76%-96%)
  • FUS/CREB3 L1 (4%-6%)
  • Low to moderate cellularity
  • Regular medium sized nuclei
  • Loosely arranged fascicles of bland spindle cells (whorling pattern)
  • Loose myxoid stroma
  • No cellular atypia
  • Hypocellular/myxoid areas in nodules merging with collagenised areas
Positive for:
  • MUC4 (highly specific and sensitive)
  • Vimentin

Occasionally positive for:

  • Desmin
  • SMA
  • EMA
  • CD34

Negative for:

  • Keratin
  • Actin
  • S100
  • Epithelial membrane antigen
  • CD31
  • CD68
  • Cytokeratin
  • (AE1/AE3)
  • Leu-7
  • Neuron-specific enolase
  • Benign (histological appearance)
  • High metastasizing potential/local aggressive infiltration
  • High local recurrence
_
Majority occurring in subfascial location and rarely involving subcutis or dermis in following sites:
  • Lower extremities
  • Trunk
  • Groin
  • Upper extremities
  • Thorax
  • Buttocks
  • Abdominal wall
  • Maxillofacial region (rarely)
  • Painless, slow-growing well-circumscribed mass
  • Average size-5cm (ranges from 1-20cm)
_
Solitary fibrous tumor (SFT) [15][16][17][18][19][20][21][22][23] Intra-chromosomal inversion at:
  • Chromosome 12q13 leading to formation of NAB2–STAT6 chimeric fusion gene (highly variable breakpoints)

TERT promoter mutations responsible for:

  • High aggressive potential
  • Metastatic potential
  • Fibroblast-like tumor cells arranged in a “patternless” pattern
  • Collagenous stroma with staghorn, hyalinized blood vessels
  • Increased mitotic activity
  • Hypercellularity
  • Nuclear atypia
  • Pleomorphism
  • Lipomatous, myxoid, or dedifferentiated variants
Positive for:
  • CD34
  • Vimentin
  • CD99 (013)

In few cases, positive for:

  • Focal keratin reactivity
  • Focal desmin reactivity

Negative for:

  • CD31
  • Cytokeratin
  • Glial fibrillary acidic protein
  • Smooth muscle actin
  • S-100 protein
  • Epithelial membrane antigen
  • Metastasis(10%-20%)
  • Recurrence (10%-20%)
_
  • Any anatomic site
  • Serosal membranes such as:
    • Pleura (most common site)
    • Dura of the meninges
    • Peritoneum (or peritoneal cavity)
  • Thoracic cavity (mediastinum, lung parenchyma)
  • Intra-abdominal SFTs involve:
    • Retroperitoneal soft tissue (most common)
    • Liver
    • Diaphragm
    • Pelvis visceras (bladder, prostate, seminal vesicle, kidney)
  • Head and neck sites include:
    • sinonasal tract
    • oral cavity
    • orbit
    • buccal mucosa
    • tongue
    • lower lip
  • Extremities
  • Skin (dermis)
  • Bone
  • Asymptomatic
  • Pulmonary symptoms (cough, shortness of breath, chest pain, hemoptysis, obstructive pneumonitis because of airway obstruction)
  • Intra-abdominal symptoms (pain,weight loss, dysuria, urinary retention, hydronephrosis, nocturia, constipation, incontinence, vomiting)
  • Paresthesias
  • Symptoms due to nerve impingement
  • Meningeal symptoms
  • Hypoglycemia (due to paraneoplastic syndromes)
  • Symptoms due to hypertrophic pulmonary osteoarthropathy include:
    • Clubbing of the fingers
    • Periostitis
    • Synovial effusions
Paraneoplastic syndromes associated with SFTs include:
  • Doege-Potter syndrome (Refractory hypoglycemia due to IGF2, associated with large peritoneal/pleural tumors)
  • Hypertrophic pulmonary osteoarthropathy (HPO)/Pierre-Marie-Bamberger syndrome( in pleuropulmonary SFTs, secretes hyaluronic acid, cytokines)
Gardner fibroma/Gardner-associated fibroma (GAF)[24][25][6][26]
  • APC gene mutation
  • Thick haphazardly arranged collagen bundles (greater abundance of collagen)
  • Few interspersed spindle cells of fibroblast type (less cellularity)
Positive for:
  • Nuclear Beta-catenin (highly positive)
  • CD34
  • Cyclin-D1
  • C-myc
  • Benign
  • Gardner-type familial adenomatous polyposis
  • Germline mutations in APC gene
  • Inherited desmoids
  • Gardner syndrome
  • The presence of nuchal-type fibroma may indicate Gardner Fibroma, when seen in children
Any part of body:
  • Back (most common)
  • Paraspinal region (most common)
  • Chest wall
  • Abdomen
  • Head
  • Neck
  • Arms
  • Legs
  • Firm rubbery mass (not a well-circumscribed)
  • Size from 1-10 cm
  • Signs and symptoms due to associated FAP or Gardner syndrome
  • Precursor lesion for desmoid (50% cases) with a more cellular appearance
  • Precursor lesion for colonic adenomas in asymptomatic FAP patients
Gastrointestinal stromal tumor (GIST)[27][28][29][30][31] Activating mutation of:

Pediatric GISTs (SDH-deficient) have mutations of one of the:

  • SDH (succinate dehydrogenase)gene subunits

GIST as a part of Carney triad has following mutation:

  • Hypermethylation of the SDHC promoter causing epigenetic inactivation of the SDHC gene

Wild-type GISTs have following three molecular subtypes:

  • DHX mutations (66%)
  • SDHC promoter hypermethylation (22%)
  • SDH competent (12%) which can further be broken into:
    • NF1 mutations
    • BRAF V600E mutations
    • Other rare mutations or fusions
    • No identified abnormality
GIST cells basically arise from interstitial cells of Cajal (ICCs) and appear as follows on histology:
  • Spindle cells (60%-80%):
    • Fascicular or whorled like appearance
    • Multiple compact cells with minimal stroma
    • Eosinophilic, basophilic or amphophilic cytoplasm
  • Epithelioid cells (20%-30%)
    • Clearly defined with an abundant amphophiliccytoplasm
  • Pleomorphic/mixed cells (occasionally, 10%)
    • Both spindle or epitheloid cells
Positive for:
  • CD117 (overexpression of the receptor tyrosine kinase KIT is the most prominent diagnostic test)
  • CD34
  • DOG-1
  • PKC-theta (protein kinase C theta)
  • Malignant potential (esophageal and colonal GIST)
  • Metastasis (to liver, lungs, bones, subcutis, spleen)
  • Age group of 50-80years
  • Primary familial GIST syndrome
  • Neurofibromatosis type 1 (NF1)
  • Carney-Stratakis syndrome (dyad of GISTs and paragangliomas)
  • Carney triad (GIST, paraganglioma, and pulmonary chondromas)
  • Urticaria pigmentosa
Can involve any part of GIT:
  • Stomach (most common)
  • Duodenum
  • Omentum
  • Mesentery
  • Esophagus
  • Colon
  • Peritoneum
Depending on tumor size and localization in GIT:
Inflammatory myofibroblastic tumor (IMT)[32][33][34][35][36][37][38][39][33][36] Unknown underlying etiology, may be due to inflammatory reaction to:
  • Infection
  • Underlying low grade malignancy

Mutations such as:

  • ALK (anaplastic lymphoma kinase) gene mutations in the tyrosine kinase locus at band 2p23
  • Spindle cells arranged in short fascicles with a focal storiform (whorled or cartwheel-like) architecture
  • Spindle cells show features of fibroblasts and myofibroblasts
  • Variably dense, chronic, mixed polymorphic infiltrate of mononuclear inflammatory (plasma cells and lymphocytes, histiocytes, neutrophils, and occasional eosinophils)
  • Histiocytes have multinucleated forms with finely vacuolated cytoplasmic lipid droplets
  • Plasma cells with cytoplasmic Russell bodies (globular cytoplasmic inclusions of immunoglobulin) and polyclonal pattern of light chain expression
  • Absent hyperchromasia and atypical mitoses
  • IG+ (plasma cells)
  • IL-1
  • IL-6
  • Smooth muscle actin
  • Desmin
  • Calponin
  • Metastatic
  • Multiorgan disease in association with chronic persistent Eikenella corrodens infection
  • Epstein Barr virus infection
  • Human herpes virus (HHV)-8 infection (Kaposi's sarcoma, multicentric Castleman's disease)
  • Lungs
  • Bladder
  • Gastrointestinal system
  • Pelvic region
  • Retroperitoneum
  • Skin
  • Bone
  • CNS
  • Soft tissues
  • Larynx
  • Uterus
  • Asymptomatic (70%)
  • Mass/lump/swelling
  • Pulmonary IMT presents as:
    • Cough
    • Dyspnea
    • Chest pain
    • Hemoptysis
Also known as:
  • Pseudo-inflammatory tumors
  • Inflammatory pseudotumor
  • Plasma cell granuloma
  • Inflammatory pseudotumor
  • Fibrous histiocytoma
  • Fibroxanthoma
  • Xanthogranuloma
  • Inflammatory pseudosarcoma
Sclerosing mesenteritis
Retroperitoneal fibrosis
Acute hematoma
Lymphoma
Rhabdomyosarcoma
Liposarcoma
Neurofibroma Positive for:
  • S100
Nodular fasciitis
Hypertrophic scars
Keloids
Benign fibrous tumor
Primitive neuroectodermal tumor

Reference

  1. Economou, Athanasios; Pitta, Xanthi; Andreadis, Efstathios; Papapavlou, Leonidas; Chrissidis, Thomas (2011). "Desmoid tumor of the abdominal wall: a case report". Journal of Medical Case Reports. 5 (1): 326. doi:10.1186/1752-1947-5-326. ISSN 1752-1947.
  2. Kasper B, Ströbel P, Hohenberger P (2011). "Desmoid tumors: clinical features and treatment options for advanced disease". Oncologist. 16 (5): 682–93. doi:10.1634/theoncologist.2010-0281. PMC 3228186. PMID 21478276.
  3. Carlson JW, Fletcher CD (2007). "Immunohistochemistry for beta-catenin in the differential diagnosis of spindle cell lesions: analysis of a series and review of the literature". Histopathology. 51 (4): 509–14. doi:10.1111/j.1365-2559.2007.02794.x. PMID 17711447.
  4. 4.0 4.1 Wu X, Petrovic V, Torode IP, Chow CW (2009). "Low grade fibromyxoid sarcoma: problems in the diagnosis and management of a malignant tumour with bland histological appearance". Pathology. 41 (2): 155–60. doi:10.1080/00313020802579276. PMID 19152188.
  5. 5.0 5.1 Bartuma H, Möller E, Collin A, Domanski HA, Von Steyern FV, Mandahl N; et al. (2010). "Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma". Cancer Genet Cytogenet. 199 (2): 143–6. doi:10.1016/j.cancergencyto.2010.02.011. PMID 20471519.
  6. 6.0 6.1 Wehrli BM, Weiss SW, Yandow S, Coffin CM (2001). "Gardner-associated fibromas (GAF) in young patients: a distinct fibrous lesion that identifies unsuspected Gardner syndrome and risk for fibromatosis". Am J Surg Pathol. 25 (5): 645–51. PMID 11342777.
  7. Coffin CM, Hornick JL, Fletcher CD (2007). "Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases". Am J Surg Pathol. 31 (4): 509–20. doi:10.1097/01.pas.0000213393.57322.c7. PMID 17414097.
  8. Swartz RD (2009). "Idiopathic retroperitoneal fibrosis: a review of the pathogenesis and approaches to treatment". Am J Kidney Dis. 54 (3): 546–53. doi:10.1053/j.ajkd.2009.04.019. PMID 19515472.
  9. Doyle LA, Möller E, Dal Cin P, Fletcher CD, Mertens F, Hornick JL (2011). "MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma". Am J Surg Pathol. 35 (5): 733–41. doi:10.1097/PAS.0b013e318210c268. PMID 21415703.
  10. Lee AF, Yip S, Smith AC, Hayes MM, Nielsen TO, O'Connell JX (2011). "Low-grade fibromyxoid sarcoma of the perineum with heterotopic ossification: case report and review of the literature". Hum Pathol. 42 (11): 1804–9. doi:10.1016/j.humpath.2011.01.023. PMID 21658743.
  11. Brasanac D, Dzelatovic NS, Stojanovic M (2013). "Giant cystic superficial low-grade fibromyxoid sarcoma". Ann Diagn Pathol. 17 (2): 222–5. doi:10.1016/j.anndiagpath.2011.09.001. PMID 22136982.
  12. Vernon SE, Bejarano PA (2006). "Low-grade fibromyxoid sarcoma: a brief review". Arch Pathol Lab Med. 130 (9): 1358–60. doi:10.1043/1543-2165(2006)130[1358:LFSABR]2.0.CO;2. PMID 16948525.
  13. Lane KL, Shannon RJ, Weiss SW (1997). "Hyalinizing spindle cell tumor with giant rosettes: a distinctive tumor closely resembling low-grade fibromyxoid sarcoma". Am J Surg Pathol. 21 (12): 1481–8. PMID 9414192.
  14. Nielsen GP, Selig MK, O'Connell JX, Keel SB, Dickersin GR, Rosenberg AE (1999). "Hyalinizing spindle cell tumor with giant rosettes: a report of three cases with ultrastructural analysis". Am J Surg Pathol. 23 (10): 1227–32. PMID 10524523.
  15. Hanau CA, Miettinen M (1995). "Solitary fibrous tumor: histological and immunohistochemical spectrum of benign and malignant variants presenting at different sites". Hum Pathol. 26 (4): 440–9. PMID 7705824.
  16. de Saint Aubain Somerhausen N, Rubin BP, Fletcher CD (1999). "Myxoid solitary fibrous tumor: a study of seven cases with emphasis on differential diagnosis". Mod Pathol. 12 (5): 463–71. PMID 10349983.
  17. Cranshaw IM, Gikas PD, Fisher C, Thway K, Thomas JM, Hayes AJ (2009). "Clinical outcomes of extra-thoracic solitary fibrous tumours". Eur J Surg Oncol. 35 (9): 994–8. doi:10.1016/j.ejso.2009.02.015. PMID 19345055.
  18. England DM, Hochholzer L, McCarthy MJ (1989). "Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases". Am J Surg Pathol. 13 (8): 640–58. PMID 2665534.
  19. Demicco EG, Park MS, Araujo DM, Fox PS, Bassett RL, Pollock RE; et al. (2012). "Solitary fibrous tumor: a clinicopathological study of 110 cases and proposed risk assessment model". Mod Pathol. 25 (9): 1298–306. doi:10.1038/modpathol.2012.83. PMID 22575866.
  20. van Houdt WJ, Westerveld CM, Vrijenhoek JE, van Gorp J, van Coevorden F, Verhoef C; et al. (2013). "Prognosis of solitary fibrous tumors: a multicenter study". Ann Surg Oncol. 20 (13): 4090–5. doi:10.1245/s10434-013-3242-9. PMID 24052313.
  21. Chmielecki J, Crago AM, Rosenberg M, O'Connor R, Walker SR, Ambrogio L; et al. (2013). "Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors". Nat Genet. 45 (2): 131–2. doi:10.1038/ng.2522. PMC 3984043. PMID 23313954.
  22. Robinson DR, Wu YM, Kalyana-Sundaram S, Cao X, Lonigro RJ, Sung YS; et al. (2013). "Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing". Nat Genet. 45 (2): 180–5. doi:10.1038/ng.2509. PMC 3654808. PMID 23313952.
  23. Schweizer L, Koelsche C, Sahm F, Piro RM, Capper D, Reuss DE; et al. (2013). "Meningeal hemangiopericytoma and solitary fibrous tumors carry the NAB2-STAT6 fusion and can be diagnosed by nuclear expression of STAT6 protein". Acta Neuropathol. 125 (5): 651–8. doi:10.1007/s00401-013-1117-6. PMID 23575898.
  24. Coffin, Cheryl M.; Hornick, Jason L.; Zhou, Holly; Fletcher, Christopher D.M. (2007). "Gardner Fibroma: A Clinicopathologic and Immunohistochemical Analysis of 45 Patients With 57 Fibromas". The American Journal of Surgical Pathology. 31 (3): 410–416. doi:10.1097/01.pas.0000213348.65014.0a. ISSN 0147-5185.
  25. Dahl, Nathan A.; Sheil, Amy; Knapke, Sarah; Geller, James I. (2016). "Gardner Fibroma". Journal of Pediatric Hematology/Oncology. 38 (5): e154–e157. doi:10.1097/MPH.0000000000000493. ISSN 1077-4114.
  26. Schäfer M, Kadmon M, Schmidt W, Treiber I, Moog U, Sutter C; et al. (2016). "Neonatal Gardner Fibroma Leads to Detection of Familial Adenomatous Polyposis: Two Case Reports". European J Pediatr Surg Rep. 4 (1): 17–21. doi:10.1055/s-0036-1582443. PMC 5177561. PMID 28018803.
  27. Zarkavelis G, Petrakis D, Pavlidis N (2015). "Gastrointestinal stromal tumors during pregnancy: a systematic review of an uncommon but treatable malignancy". Clin Transl Oncol. 17 (10): 757–62. doi:10.1007/s12094-015-1315-x. PMID 26055339.
  28. Navarrete A, Momblán D, Almenara R, Lacy A (2017). "Giant Gastric Gastrointestinal Stromal Tumor (GIST)". J Gastrointest Surg. 21 (1): 202–204. doi:10.1007/s11605-016-3196-x. PMID 27384431.
  29. Scherjon S, Lam WF, Gelderblom H, Jansen FW (2009). "Gastrointestinal stromal tumor in pregnancy: a case report". Case Rep Med. 2009: 456402. doi:10.1155/2009/456402. PMC 2745024. PMID 19763238.
  30. Acín-Gándara D, Pereira-Pérez F, Castaño-Pascual A, Durán-Poveda M, Antequera-Pérez A, Miliani-Molina C (2012). "Gastrointestinal stromal tumors: diagnosis and treatment". Cir Cir. 80 (1): 44–51. PMID 22472152.
  31. Lanzafame S, Minutolo V, Caltabiano R, Minutolo O, Marino B, Gagliano G; et al. (2006). "About a case of GIST occurring during pregnancy with immunohistochemical expression of epidermal growth factor receptor and progesterone receptor". Pathol Res Pract. 202 (2): 119–23. doi:10.1016/j.prp.2005.08.013. PMID 16413690.
  32. Coffin CM, Watterson J, Priest JR, Dehner LP (1995). "Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases". Am J Surg Pathol. 19 (8): 859–72. PMID 7611533.
  33. 33.0 33.1 Wenig BM, Devaney K, Bisceglia M (1995). "Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm". Cancer. 76 (11): 2217–29. PMID 8635024.
  34. Ramachandra S, Hollowood K, Bisceglia M, Fletcher CD (1995). "Inflammatory pseudotumour of soft tissues: a clinicopathological and immunohistochemical analysis of 18 cases". Histopathology. 27 (4): 313–23. PMID 8847061.
  35. Häusler M, Schaade L, Ramaekers VT, Doenges M, Heimann G, Sellhaus B (2003). "Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review". Hum Pathol. 34 (3): 253–62. doi:10.1053/hupa.2003.35. PMID 12673560.
  36. 36.0 36.1 Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA (2005). "Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors". Am J Surg Pathol. 29 (10): 1348–55. PMID 16160478.
  37. Kovach SJ, Fischer AC, Katzman PJ, Salloum RM, Ettinghausen SE, Madeb R; et al. (2006). "Inflammatory myofibroblastic tumors". J Surg Oncol. 94 (5): 385–91. doi:10.1002/jso.20516. PMID 16967468.
  38. Coffin CM, Dehner LP, Meis-Kindblom JM (1998). "Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations". Semin Diagn Pathol. 15 (2): 102–10. PMID 9606802.
  39. Berardi RS, Lee SS, Chen HP, Stines GJ (1983). "Inflammatory pseudotumors of the lung". Surg Gynecol Obstet. 156 (1): 89–96. PMID 6336632.

Template:WikiDoc Sources